Glass House Brands (GLAS) Accounts Payables (2020 - 2026)
Glass House Brands' (GLAS) quarterly Accounts Payables came in at $38.1 million in Q1 2026, up 23.96% year-on-year from $30.7 million in Q1 2025, and up 5.83% on a QoQ basis from $36.0 million in Q4 2025.
Glass House Brands (GLAS) Accounts Payables (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Accounts Payables data on file, last reported at $38.1 million in Q1 2026.
- On a quarterly basis, Accounts Payables rose 23.96% year-over-year to $38.1 million in Q1 2026; TTM through Mar 2026 was $38.1 million, a 23.96% increase from a year earlier, with the FY2025 full-year figure at $36.0 million, up 15.56% from the prior year.
- Accounts Payables for Q1 2026 stood at $38.1 million, up from $36.0 million in the prior quarter.
- Over the last five years, Accounts Payables for GLAS reached as high as $38.1 million in Q1 2026 and fell as low as $7.3 million in Q1 2022.
- Historically, Accounts Payables has averaged $27.6 million across 5 years, with a median of $28.8 million in 2025.
- Across the five-year window, Accounts Payables plunged 56.96% in 2022 and surged 236.48% in 2023, its largest moves.
- Year by year, Accounts Payables stood at $22.0 million in 2022, then advanced by 22.59% to $26.9 million in 2023, then rose by 15.58% to $31.1 million in 2024, then climbed by 15.56% to $36.0 million in 2025, then climbed by 5.83% to $38.1 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $38.1 million in Q1 2026, $36.0 million in Q4 2025, and $28.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 498.30 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 731,000.00 |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 38.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.07 Mn |
| Dec 31, 2025 | 35.97 Mn |
| Sep 30, 2025 | 28.76 Mn |
| Jun 30, 2025 | 37.53 Mn |
| Mar 31, 2025 | 30.71 Mn |
| Dec 31, 2024 | 31.13 Mn |
| Sep 30, 2024 | 32.75 Mn |
| Jun 30, 2024 | 33.74 Mn |
| Mar 31, 2024 | 29.77 Mn |
| Dec 31, 2023 | 26.93 Mn |
| Sep 30, 2023 | 27.74 Mn |
| Jun 30, 2023 | 28.03 Mn |
| Mar 31, 2023 | 24.63 Mn |
| Dec 31, 2022 | 21.97 Mn |
| Sep 30, 2022 | 23.01 Mn |
| Jun 30, 2022 | 11.92 Mn |
| Mar 31, 2022 | 7.32 Mn |
| Dec 31, 2021 | 9.94 Mn |
| Sep 30, 2021 | 18.03 Mn |
| Jun 30, 2021 | 19.60 Mn |